Clinical Trials for Vantictumab

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCGI1370
12/30/2013
A Phase 1b Dose Escalation Study of Vantictumab (OMP-18R5) in Combination with Nab-Paclitaxel and Gemcitabine in Patients with Previously Untreated Stage IV Pancreatic Cancer

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.